MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.57 +3.11%

+$0.39 today

Market cap
$280.00M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.55M

Average 0.73M

Price history

MapLight Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-55.82%

Period high

$39.80

Period low

$6.22

Latest

$6.57

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Oct 16, 2026Oct 16, 2026
4Oct 16, 2026Oct 16, 2026
4Oct 16, 2026Oct 16, 2026
4Oct 16, 2026Oct 16, 2026
4Oct 16, 2026Oct 16, 2026
4Oct 16, 2026Oct 16, 2026
EFFECTSep 23, 2026Sep 24, 2026
424B3Sep 23, 2026Sep 23, 2026
S-1/ASep 18, 2026Sep 18, 2026
4Sep 18, 2026Sep 18, 2026
144Sep 16, 2026Sep 16, 2026
S-1Sep 9, 2026Sep 9, 2026
SC 13GAug 20, 2026Aug 20, 2026
4Aug 19, 2026Aug 19, 2026
4Aug 19, 2026Aug 19, 2026

Competitors

Who does MapLight Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MPLT's filings, answered from its disclosures.

What is the latest MPLT filing?

The latest filing shown is 4 dated Oct 16, 2026.

How many recent filings does MPLT have?

Intrinsic Alpha currently shows 20 recent filings for MPLT.